Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 06, 2022

BUY
$13.19 - $22.1 $4,286 - $7,182
325 New
325 $12,000
Q2 2022

Aug 12, 2022

SELL
$13.19 - $22.1 $4,286 - $7,182
-325 Closed
0 $0
Q4 2021

Jan 12, 2022

BUY
$22.41 - $37.54 $7,283 - $12,200
325 New
325 $8,000

Others Institutions Holding DICE

About DICE Therapeutics, Inc.


  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.